Microwave Breast Lesion Classification – Results from Clinical Investigation of the SAFE Microwave Breast Cancer System

We are excited to announce the publication of our latest study titled "Microwave Breast Lesion Classification – Results from Clinical Investigation of the SAFE Microwave Breast Cancer System." This study represents a significant step forward in our ongoing efforts to improve breast cancer screening and early detection using innovative microwave imaging technology.

About the Publication:

The abstract provides an overview of the study, highlighting the use of microwave breast cancer imaging (MWI) and machine learning (ML) techniques to assess breast tissue pathology. The study evaluates the SAFE MWI system's capability to provide breast pathology and reports promising results in terms of sensitivity, specificity, and accuracy.

Key Findings:

• The study included 113 breast samples, with 70 benign and 43 malignant cases.
• The Adaptive Boosting (AdaBoost) ML model achieved a sensitivity of 79%, specificity of 77%, and an overall accuracy of 78% in classifying breast lesions.
• The non-ionizing and non-invasive nature of SAFE makes it a promising tool for breast cancer screening and early detection.
• Further clinical studies are planned to validate the findings and explore SAFE's potential impact on breast cancer diagnosis.

Access the Publication:

To read the full publication and explore the detailed findings of our clinical investigation, please follow this link.

We are proud to contribute to the advancement of breast cancer diagnosis and remain committed to developing technologies that can make a positive impact on patient care. We invite you to delve into the study and join us in our mission to improve breast cancer screening and diagnosis through innovation and research.